• GSK establishes AI hub in London to discover new drugs pharmaceutical-technology
    September 07, 2020
    GlaxoSmithKline (GSK) has opened a £10m research hub in King’s Cross, London, UK, to leverage artificial intelligence (AI) for the discovery of new drugs to treat cancer and other diseases.
PharmaSources Customer Service